160 related articles for article (PubMed ID: 31633190)
1. Oculoectodermal Syndrome - Encephalocraniocutaneous Lipomatosis Associated with NRAS Mutation.
Richters RJH; Seyger MMB; Meeuwis KAP; Rinne T; Eijkelenboom A; Willemsen MA
Acta Derm Venereol; 2020 Apr; 100(8):adv00103. PubMed ID: 31633190
[No Abstract] [Full Text] [Related]
2. Specific mosaic KRAS mutations affecting codon 146 cause oculoectodermal syndrome and encephalocraniocutaneous lipomatosis.
Boppudi S; Bögershausen N; Hove HB; Percin EF; Aslan D; Dvorsky R; Kayhan G; Li Y; Cursiefen C; Tantcheva-Poor I; Toft PB; Bartsch O; Lissewski C; Wieland I; Jakubiczka S; Wollnik B; Ahmadian MR; Heindl LM; Zenker M
Clin Genet; 2016 Oct; 90(4):334-42. PubMed ID: 26970110
[TBL] [Abstract][Full Text] [Related]
3. Expansion of the phenotypic spectrum and description of molecular findings in a cohort of patients with oculocutaneous mosaic RASopathies.
Chacon-Camacho OF; Lopez-Moreno D; Morales-Sanchez MA; Hofmann E; Pacheco-Quito M; Wieland I; Cortes-Gonzalez V; Villanueva-Mendoza C; Zenker M; Zenteno JC
Mol Genet Genomic Med; 2019 May; 7(5):e625. PubMed ID: 30891959
[TBL] [Abstract][Full Text] [Related]
4. Mosaic KRAS mutation in a patient with encephalocraniocutaneous lipomatosis and renovascular hypertension.
McDonell LM; Leung GK; Daoud H; Ip J; Chim S; Luk HM; Lan L; ; Boycott KM; Chung BH
Am J Med Genet A; 2018 Nov; 176(11):2523-2527. PubMed ID: 30289595
[No Abstract] [Full Text] [Related]
5. Giant Ocular Lipodermoid Cyst in Encephalocraniocutaneous Lipomatosis: Surgical Treatment and Genetic Analysis.
Córdoba A; Graue-Hernández EO; Navas A; Chacon-Camacho OF; Zenteno JC; Ramirez-Miranda A; Bermudez-Magner JA; Ordaz-Robles T; Pérez-Solórzano S; Olivo-Payne A
Am J Case Rep; 2019 Oct; 20():1566-1571. PubMed ID: 31649234
[TBL] [Abstract][Full Text] [Related]
6. Encephalocraniocutaneous lipomatosis: A case report with review of literature.
Siddiqui S; Naaz S; Ahmad M; Khan ZA; Wahab S; Rashid BA
Neuroradiol J; 2017 Dec; 30(6):578-582. PubMed ID: 28707961
[TBL] [Abstract][Full Text] [Related]
7. RASopathies.
Jafry M; Sidbury R
Clin Dermatol; 2020; 38(4):455-461. PubMed ID: 32972603
[TBL] [Abstract][Full Text] [Related]
8. Encephalocraniocutaneous Lipomatosis.
Bavle A; Shah R; Gross N; Gavula T; Ruiz-Elizalde A; Wierenga K; McNall-Knapp R
J Pediatr Hematol Oncol; 2018 Oct; 40(7):553-554. PubMed ID: 29683947
[TBL] [Abstract][Full Text] [Related]
9. Encephalocraniocutaneous Lipomatosis Without Ocular Malformations.
Radić Nišević J; Prpić I; Antulov R; Sasso A; Holjar Erlić I
Pediatr Neurol; 2016 Jul; 60():71-4. PubMed ID: 27131628
[TBL] [Abstract][Full Text] [Related]
10. Imaging findings in encephalocraniocutaneous lipomatosis.
Svoronos A; Hirsch LJ; Khandji AG
Neurology; 2011 Aug; 77(7):694. PubMed ID: 21844526
[No Abstract] [Full Text] [Related]
11. Encephalocraniocutaneous lipomatosis.
Levy ML; Massey C
Handb Clin Neurol; 2015; 132():265-9. PubMed ID: 26564086
[TBL] [Abstract][Full Text] [Related]
12. Encephalocraniocutaneous lipomatosis (ECCL): neuroradiological findings in three patients and a new association with fibrous dysplasia.
Delfino LN; Fariello G; Quattrocchi CC; Aiello C; Menchini L; Devito R; Zama M; Claps D; Vigevano F; Longo D
Am J Med Genet A; 2011 Jul; 155A(7):1690-6. PubMed ID: 21626669
[TBL] [Abstract][Full Text] [Related]
13. Characteristic imaging findings in encephalocraniocutaneous lipomatosis.
Lin AW; Krings T
Neurology; 2015 Mar; 84(13):1384-5. PubMed ID: 25825465
[No Abstract] [Full Text] [Related]
14. Next generation sequencing aids diagnosis and management in a case of encephalocraniocutaneous lipomatosis.
Barry KK; Liang MG; Balkin DM; Srivastava S; Church AJ; Eng W
Pediatr Dermatol; 2024; 41(1):76-79. PubMed ID: 37486073
[TBL] [Abstract][Full Text] [Related]
15. Antenatal and postnatal findings in encephalocraniocutaneous lipomatosis.
Nowaczyk MJ; Mernagh JR; Bourgeois JM; Thompson PJ; Jurriaans E
Am J Med Genet; 2000 Apr; 91(4):261-6. PubMed ID: 10766980
[TBL] [Abstract][Full Text] [Related]
16. Sensitive detection of FGFR1 N546K mosaic mutation in patient with encephalocraniocutaneous lipomatosis and pilocytic astrocytoma.
Kordacka J; Zakrzewski K; Gruszka R; Witusik-Perkowska M; Taha J; Sikorska B; Liberski PP; Zakrzewska M
Am J Med Genet A; 2019 Aug; 179(8):1622-1627. PubMed ID: 31173478
[TBL] [Abstract][Full Text] [Related]
17. Methylome analysis and whole-exome sequencing reveal that brain tumors associated with encephalocraniocutaneous lipomatosis are midline pilocytic astrocytomas.
Valera ET; McConechy MK; Gayden T; Rivera B; Jones DTW; Wittmann A; Han H; Bareke E; Nikbakht H; Mikael L; Queiroz RG; Suazo VK; Phi JH; Kim SK; Park SH; Fukaya R; Yum MS; Ko TS; de Oliveira RS; Machado HR; Brassesco MS; do Santos AC; Simão GN; Ramalho LNZ; Neder L; Scrideli CA; Tone LG; Majewski J; Jabado N
Acta Neuropathol; 2018 Oct; 136(4):657-660. PubMed ID: 30143858
[No Abstract] [Full Text] [Related]
18. Identification of Codon 146
Beyens A; Dequeker L; Brems H; Janssens S; Syryn H; D'Hooghe A; De Paepe P; Vanwalleghem L; Stockman A; Vankwikelberge E; De Schepper S; Goeteyn M; Delbeke P; Callewaert B
Int J Mol Sci; 2022 Apr; 23(7):. PubMed ID: 35409398
[TBL] [Abstract][Full Text] [Related]
19. Encephalocraniocutaneous lipomatosis with neurocutaneous melanosis.
Jain P; Chakrabarty B; Kumar A; Gupta N; Kabra M; Gulati S
J Child Neurol; 2014 Jun; 29(6):846-9. PubMed ID: 23620525
[TBL] [Abstract][Full Text] [Related]
20. Lipomatosis encefalocraneocutánea: reporte de caso.
Muñoz-Montufar JP; Rayo-Mares JD; Reyes-Cuayahuitl A; Pacheco-Rosas DO; Rangel-Ramírez MP
Gac Med Mex; 2017; 153(7):915-918. PubMed ID: 29414957
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
